Gooding, William E.

Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients

Theodoraki, M.-N., Yerneni, S. S., Hoffmann, T. K., Gooding, W. E., & Whiteside, T. L. (2018) · Clinical Cancer Research

Extracellular vesicles in diseaseCancer Immunotherapy and Biomarkers

Cited by 624

First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy

Sen, M., Thomas, S. M., Kim, S., Yeh, J. I., Ferris, R. L., Johnson, J. T., Duvvuri, U., Lee, J., Sahu, N., Joyce, S., et al. (2012) · Cancer Discovery

Cytokine Signaling Pathways and InteractionsRNA Interference and Gene Delivery

Cited by 313

Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer

Sen, M., Joyce, S., Panahandeh, M., Li, C., Thomas, S. M., Maxwell, J., Wang, L., Gooding, W. E., Johnson, D. E., & Grandis, J. R. (2012) · Clinical Cancer Research

HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations

Cited by 158

Analysis of Changes in Eating Behavior and Weight Loss in Type II Diabetic Patients: Which Behaviors to Change

Guare, J. C., Wing, R. R., Marcus, M. D., Epstein, L. H., Burton, L. R., & Gooding, W. E. (1989) · Diabetes Care

Diabetes Management and EducationNutrition, Health and Food Behavior

Cited by 54

Lack of toxicity of a STAT3 decoy oligonucleotide

Sen, M., Tosca, P. J., Zwayer, C., Ryan, M. J., Johnson, J. D., Knostman, K. A. B., Giclas, P. C., Peggins, J. O., Tomaszewski, J. E., McMurray, T. P., et al. (2009) · Cancer Chemotherapy and Pharmacology

Cytokine Signaling Pathways and InteractionsRNA Interference and Gene Delivery

Cited by 53